Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Microcystic macular oedema in multiple sclerosis is associated with disease severity.
Knockdown of Lingo1b protein promotes myelination and oligodendrocyte differentiation in zebrafish.
Maternal and perinatal outcomes in pregnancies with multiple sclerosis: a case-control study.
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity.
Glatiramer acetate in combination with minocycline in patients with relapsing--remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial.
Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomide.
Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials.
Foxp3(+) Treg cells in the inflamed CNS are insensitive to IL-6-driven IL-17 production.
A Unified Frequency Domain Model to Study the Effect of Demyelination on Axonal Conduction.
Glatiramer Acetate Guards Against Rapid Memory Decline During Relapsing-Remitting Experimental Autoimmune Encephalomyelitis.
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity.
IFN-β inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis.
Mylan's ANDA for Three Times Per Week Generic Copaxone® 40 mg/mL Accepted for Filing by FDA
Drugs@FDA (Enter "glatiramer acetate" in search box.)
SigmaPharm Laboratories Products
Combination therapy of interferon Beta-1b and tacrolimus: a pilot safety study.
Biogen Idec receives notification of PDUFA date extension for PLEGRIDY™ (peginterferon beta-1a)
Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results.
Beneficial actions of the anti-inflammatory dimethyl fumarate in glioblastomas.
European Medicines Agency, Scientific Discussion of MabCampath (alemtuzumab)
Subcutaneous recombinant interferon-β-1a (Rebif®): a review of its use in the treatment of relapsing multiple sclerosis.
Myelin in cartilaginous fish.
The Role of Endogenous IFN-β in the Regulation of Th17 Responses in Patients with Relapsing-Remitting Multiple Sclerosis.
Synaptic pathology: a shared mechanism in neurological disease.
The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders.

Pages